Abstract
Background Patients with severe hypertriglyceridaemia (sHTG) are often refractory to lipid-lowering therapy. Apolipoprotein (Apo) CIII inhibition coul......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
